Farmington Hills, Michigan, July 24, 2019 – LSPediA Inc., a leading software and service provider for the pharmaceutical industry, today announced that five more leading wholesale drug distributors selected LSPediA’s Verification Router Service solution for the upcoming Drug Supply Chain Security Act (DSCSA) verification requirement.
LSPediA’s proven VRS solution, OneScan®, has the largest industry coverage and the highest verification success rate. It enables wholesale distributors to authenticate drug products with a single scan in sub-second response time. OneScan® is also the industry’s only solution for exception management and drug notification (FDA 3911), allowing wholesalers and manufacturers to seamlessly collaborate on suspect product investigation and illegitimate product handling.
LSPediA’s VRS solution was selected for its full functionality, exception management, turnkey compliance, excellent customer service, and lowest total cost of ownership.
“We chose LSPediA after spending a lot of time learning about other providers and watching system demos. We want results, not waiting months to get answers. We spoke with other wholesalers who confirmed their positive experience with LSPediA, especially in receiving quick responses and personalized service. LSPediA’s system demo was the icing on the cake. It was exactly what we were looking for,” said one new customer.
Distributors need an efficient, reliable, and proven VRS solution before the November DSCSA deadline. Request a VRS demo today.
About LSPediA – Life Sciences Solutions
LSPediA is a leading supply chain software provider for the pharmaceutical industry. LSPediA’s serialization solution RxChain® and OneScan® Verification Router Service protect pharma companies against regulatory risks and improve supply chain efficiency. Pharmaceutical manufacturers, wholesale distributors, dispensers, and healthcare providers partner with LSPediA to manage serial data, distribute serialized drug products, verify the validity of the drug product.